Y-mAbs(YMAB) - 2023 Q4 - Earnings Call Transcript

Y-mAbs Therapeutics, Inc. (NASDAQ:YMAB) Q4 2023 Earnings Conference Call March 1, 2024 8:00 AM ET Company Participants Courtney Dugan - Vice President, Head of Investor Relations Michael Rossi - President and Chief Executive Officer Sue Smith - Chief Commercial Officer Vignesh Rajah - Chief Medical Officer Bo Kruse - Chief Financial Officer Conference Call Participants Alec Stranahan - Bank of America David Nierengarten - Wedbush Securities Lukas Shumway - BMO Capital Markets Operator Good morning and welco ...